Found 94 matching trials
Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care PHASE4 hepatitis C virus (HCV) has traditionally been treated in subspecialty heal...
Show More Learn More & Join Trial
Efficacy and Safety of Combination Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin (RBV) in Genotype 2 Hepatitis C Infection (MK-5172-047) PHASE2 This is a multi-site, open-label trial evaluating the safety and efficacy o...
Show More Location
Multiple Locations
Learn More & Join Trial
Elbasvir/Grazoprevir (EBR/GZR) and Sofosbuvir (SOF) With and Without Ribavirin (RBV) in Cirrhotic Subjects With Chronic Hepatitis C Virus (HCV) Genotype 3 (GT3) Infection (MK-5172-083) PHASE2 This is a randomized, multi-site, open-label trial of the co-administration...
Show More Location
Multiple Locations
Learn More & Join Trial
Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients EARLY_PHASE1 The development of direct acting anti-virals (DAAs) for the treatment of He...
Show More Location
Virginia Commonwealth University
Learn More & Join Trial
A Study of Different Durations of Treatment With Grazoprevir (MK-5172) in Combination With Ribavirin in Participants With Chronic Hepatitis C (MK-5172-039) PHASE2 This study will compare two different durations of treatment with grazoprev...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022) PHASE1 This study is divided into 2 segments, and proposes to qualify fine needle ...
Show More Location
Multiple Locations
Learn More & Join Trial
Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients. PHASE3 Pilot, single center, open-label study to evaluate the efficacy and tolerab...
Show More Location
Multiple Locations
Learn More & Join Trial
Transplanting Hepatitis C Lungs Into Negative Lung Recipients PHASE1 This study is being conducted to determine safety and effectiveness of tran...
Show More Location
Hospital of the University of Pennsylvania
Learn More & Join Trial
Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Grazoprevir (MK-5172-013) PHASE1 This study will compare the pharmacokinetics (PK) of grazoprevir (MK-5172) ...
Show More Location
Multiple Locations
Learn More & Join Trial
Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C) N/A This is a multi-center, open-label clinical study. This study was aimed to ...
Show More Location
Multiple Locations
Learn More & Join Trial